PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22369716-4	2012	These actions are observable with physiologic doses of melatonin only in cells expressing ERalpha, and mediated by MT1 melatonin receptors.	Melatonin	55-64	estrogen receptor 1	Homo sapiens	90-97	
22369716-6	2012	This double action mechanism (SERM and SEEM), and the specificity for ERalpha bestows melatonin with potential advantages for breast cancer treatments, associated with other antiestrogenic drugs, and idea already patented.	Melatonin	86-95	estrogen receptor 1	Homo sapiens	70-77